Benjamin F. Edwards & Company’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $10.1M | Buy |
104,427
+6,554
| +7% | +$605K | 0.18% | 145 |
|
|
2024
Q1 | $8.81M | Buy |
97,873
+1,737
| +2% | +$147K | 0.16% | 150 |
|
|
2023
Q4 | $7.66M | Buy |
96,136
+85,346
| +791% | +$6.42M | 0.15% | 155 |
|
|
2023
Q3 | $767K | Sell |
10,790
-64
| -0.6% | -$4.79K | 0.03% | 434 |
|
|
2023
Q2 | $836K | Sell |
10,854
-664
| -6% | -$51.4K | 0.03% | 408 |
|
|
2023
Q1 | $866K | Sell |
11,518
-169
| -1% | -$12.6K | 0.04% | 366 |
|
|
2022
Q4 | $921K | Sell |
11,687
-558
| -5% | -$41.8K | 0.04% | 344 |
|
|
2022
Q3 | $860K | Sell |
12,245
-693
| -5% | -$54.3K | 0.04% | 331 |
|
|
2022
Q2 | $1.04M | Buy |
12,938
+1,007
| +8% | +$78.7K | 0.05% | 316 |
|
|
2022
Q1 | $905K | Buy |
11,931
+2,855
| +31% | +$226K | 0.04% | 359 |
|
|
2021
Q4 | $775K | Buy |
9,076
+58
| +0.6% | +$4.53K | 0.03% | 391 |
|
|
2021
Q3 | $682K | Sell |
9,018
-254
| -3% | -$20.2K | 0.03% | 406 |
|
|
2021
Q2 | $754K | Sell |
9,272
-3,126
| -25% | -$256K | 0.04% | 380 |
|
|
2021
Q1 | $977K | Buy |
12,398
+287
| +2% | +$22.5K | 0.05% | 337 |
|
|
2020
Q4 | $1.04M | Buy |
12,111
+2,495
| +26% | +$206K | 0.06% | 293 |
|
|
2020
Q3 | $742K | Buy |
9,616
+765
| +9% | +$58.3K | 0.05% | 326 |
|
|
2020
Q2 | $648K | Sell |
8,851
-1,473
| -14% | -$105K | 0.05% | 327 |
|
|
2020
Q1 | $685K | Sell |
10,324
-2,153
| -17% | -$152K | 0.06% | 289 |
|
|
2019
Q4 | $859K | Sell |
12,477
-155
| -1% | -$10.6K | 0.06% | 296 |
|
|
2019
Q3 | $929K | Buy |
12,632
+3,173
| +34% | +$230K | 0.07% | 270 |
|
|
2019
Q2 | $678K | Sell |
9,459
-130
| -1% | -$9.23K | 0.06% | 303 |
|
|
2019
Q1 | $657K | Buy |
9,589
+563
| +6% | +$36.4K | 0.06% | 291 |
|
|
2018
Q4 | $537K | Buy |
9,026
+2,863
| +46% | +$179K | 0.06% | 293 |
|
|
2018
Q3 | $413K | Buy |
6,163
+136
| +2% | +$9.06K | 0.04% | 361 |
|
|
2018
Q2 | $391K | Buy |
6,027
+519
| +9% | +$33.9K | 0.04% | 369 |
|
|
2018
Q1 | $395K | Sell |
5,508
-10,011
| -65% | -$720K | 0.04% | 362 |
|
|
2017
Q4 | $1.17M | Buy |
15,519
+1,615
| +12% | +$118K | 0.12% | 181 |
|
|
2017
Q3 | $1.01M | Buy |
13,904
+1,764
| +15% | +$127K | 0.12% | 172 |
|
|
2017
Q2 | $900K | Sell |
12,140
-602
| -5% | -$44.7K | 0.12% | 180 |
|
|
2017
Q1 | $933K | Buy |
12,742
+698
| +6% | +$48.9K | 0.14% | 166 |
|
|
2016
Q4 | $788K | Buy |
12,044
+705
| +6% | +$48.3K | 0.13% | 173 |
|
|
2016
Q3 | $841K | Sell |
11,339
-4
| -0% | -$296 | 0.15% | 151 |
|
|
2016
Q2 | $830K | Sell |
11,343
-1,426
| -11% | -$102K | 0.16% | 143 |
|
|
2016
Q1 | $902K | Buy |
12,769
+341
| +3% | +$22.7K | 0.19% | 122 |
|
|
2015
Q4 | $828K | Sell |
12,428
-203
| -2% | -$13.5K | 0.18% | 127 |
|
|
2015
Q3 | $802K | Buy |
12,631
+1,154
| +10% | +$75.4K | 0.18% | 125 |
|
|
2015
Q2 | $751K | Sell |
11,477
-1,832
| -14% | -$124K | 0.15% | 146 |
|
|
2015
Q1 | $923K | Buy |
13,309
+2,370
| +22% | +$164K | 0.19% | 115 |
|
|
2014
Q4 | $757K | Buy |
10,939
+602
| +6% | +$40.7K | 0.18% | 133 |
|
|
2014
Q3 | $674K | Buy |
10,337
+1,410
| +16% | +$93K | 0.17% | 144 |
|
|
2014
Q2 | $609K | Buy |
8,927
+81
| +0.9% | +$5.43K | 0.15% | 153 |
|
|
2014
Q1 | $574K | Buy |
8,846
+2,922
| +49% | +$184K | 0.16% | 150 |
|
|
2013
Q4 | $386K | Buy |
5,924
+129
| +2% | +$8.26K | 0.13% | 174 |
|
|
2013
Q3 | $344K | Buy |
5,795
+915
| +19% | +$54.2K | 0.13% | 170 |
|
|
2013
Q2 | $280K | Buy |
+4,880
| New | +$290K | 0.11% | 174 |
|
Other funds holding CL
Benjamin F. Edwards & Company's CL Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Colgate-Palmolive (CL) stake by 6.7% in Q2 2024, buying an estimated $605K and bringing the position to 104,427 shares worth $10.1M. The position accounts for 0.18% of the portfolio, ranked #145.
Benjamin F. Edwards & Company first reported a position in CL in Q2 2013 and has held it in 45 quarters since. 1,820 funds tracked by Wall St. Rank hold CL as of Q2 2024.
- Benjamin F. Edwards & Company held 104,427 shares of Colgate-Palmolive worth $10.1M as of Q2 2024.
- Benjamin F. Edwards & Company bought 6,554 Colgate-Palmolive shares in Q2 2024, an estimated $605K.
- Colgate-Palmolive made up 0.18% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #145 holding.
- Benjamin F. Edwards & Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 45 quarters since.
- 1,820 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.